Pityriasis lichenoides-like exanthem and primary infection by Epstein-Barr virus

International Journal of Dermatology

Volumn 39, Issue 2, 2000, Pages 156-159

  Almagro, Manuel ^a   Del Pozo, Jesús ^a   Martínez, Walter ^a   García Silva, Jesús ^a   Peña, Carmen ^a   Yebra Pimentel, Maria T ^a   Fonseca, Eduardo ^a  

^a HOSPITAL JUAN CANALEJO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR;

ADULT; ARTICLE; CASE REPORT; EPSTEIN BARR VIRUS; HUMAN; MALE; PAPULE; PARAKERATOSIS; PITYRIASIS LICHENOIDES; PURPURA; RASH; SKIN NECROSIS; VIRUS INFECTION;

ACYCLOVIR; ADULT; ANTIBODIES, VIRAL; ANTIVIRAL AGENTS; EPSTEIN-BARR VIRUS INFECTIONS; EXANTHEMA; HERPESVIRUS 4, HUMAN; HUMANS; MALE; PITYRIASIS;

EID: 0034100884     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.2000.00890.x     Document Type: Article

References (20)

1. Almagro M, Del Pozo J, García-Silva J, Fonseca E. Manifestaciones cutáneas de la infecci'n por el Virus de Epstein Barr. Monograf Dermatol 1997; 10: 84-94.
2. Baldar N, Cancellieri C, Celli B, et al. Skin disorders and Epstein-Barr virus primary infection: results of a 31 month survey. J Eur Acad Dermatol Venereol 1995; 4: 239-247.
3. Caussade P, Katz JC, Heid GE. Infection humaine a virus Epstein Barr (VEB). Manifestacions dermatologiques. Ann Dermatol Venereol 1987; 114: 289-300.
4. McCarthy JT, Hoagland CRJ. Cutaneous manifestations of infectious mononucleosis. JAMA 1964; 187: 153-154.
5. Tsai TF, Chen RL, Su IJ, et al. Epstein-Barr virus-associated lymphoproliferative disorder of granular lymphocytes presenting initially as a cutaneous vasculitis. J Am Acad Dermatol 1994; 30: 339-344.
6. L'pez D, Puig L, Llobet JM, Moragas JM. Vasculitis necrosante cutánea como forma de presentaci'n de la mononucleosis infecciosa. Med Clin (Barc) 1988; 91: 756-757.
7. Del Pozo J, Almagro M, García-Silva J, et al. Flexural purpura and Epstein-Barr virus infection. Int J Dermatol 1998; 37: 130-132.
8. Schooley RT. Epstein-Barr virus (infectious mononucleosis). In: Mandell GL, Douglas RG, Bennet JE, eds. Principles and Practice of Infectious Diseases. New York: Churchill Livingstone, 1995: 1364-1367.
9. Milne J. Infectious mononucleosis. N Engl J Med 1945; 233: 727.
10. Fermand JP, Gozlan J, Bendelac A, et al. Detection of Epstein-Barr virus in epidermal lesions of an immunocompromised patient. Ann Intern Med 1990; 112: 511-515.
11. Freeman MJ, Taylor JS, Levin HS, et al. Histiocytic medullary reticulosis presenting as Mucha-Habermann disease. Acta Derm Venereol (Stockh) 1978; 58: 57-64.
12. Rongioletti F, Rivara G, Rebora A. Pityriasis lichenoides et varioliformis acuta and acquired toxoplasmosis. Dermatologica 1987; 175: 41-44.
13. Isoda M. Pityriasis lichenoides-like eruption occurring during therapy for myelogenous leukemia. J Dermatol 1989; 16: 73-75.
14. Stosiek N, Peters KP, Von den Driesch P. Pityriasis lichenoides et varioliformis acuta-like drug exanthema caused by astemizole. Hautarzt 1993; 44: 235-237.
15. English JC 3rd, Collins M, Bryant-Bruce C. Pityriasis lichenoides et varioliformis acuta and group-A beta hemolytic streptococcal infection. Int J Dermatol 1995; 34: 642-644.
16. Smith KJ, Nelson A, Skelton H, et al. Pityriasis lichenoides et varioliformis acuta in HIV+ patients: a marker of early stage disease. The Military Medical Consortium for the Advancement of Retroviral Research (MMCARR). Int J Dermatol 1997; 36: 104-109.
17. Labarthe MP, Salomon D, Saurat JH. Ulcers of the tongue, pityriasis lichenoides and primary parvovirus 619 infection. Ann Dermatol Venereol 1996; 123: 735-738.
18. Weese A. Pityriasis lichenoides subacuta under the clinical picture of a secondary lues. Z Hautkr 1997; 52: 372-373.
19. Boss JM, Boxley JD, Summerly R, Sutton RNP. The detection of Epstein-Barr virus antibody in 'exanthematic' dermatoses with special reference to pityriasis lichenoides. Clin Exp Dermatol 1978; 3: 51-56.
20. Edwards BL, Bonagura VR, Valacer DJ, Ilowite NT. Mucha-Habermann's disease and arthritis: possible association with reactivated Epstein-Barr virus infection. J Rheumatol 1989; 16: 387-389.